Bicarbonate Effects on Antibacterial Immunity and Mucus Glycobiology in the Cystic Fibrosis Lung: A Review With Selected Experimental Observations. Issue 3 (16th August 2022)

• Record Type: Journal Article
• Authors: Siew, Ruth; Ou, Tzung-Lin; Dahesh, Samira; Akong, Kathryn; Nizet, Victor
• Is Part Of: Infectious microbes & diseases. Volume 4:Issue 3(2022)
• Page Start: 103
• Page End: 110
• Publication Date: 2022-08-16
• Subjects: cystic fibrosis -- bicarbonate -- mucus -- pneumonia -- bacterial infection -- neutrophil -- cathelicidin -- neutrophil extracellular traps; Medical microbiology -- Periodicals; Communicable diseases -- Periodicals; Communicable diseases; Medical microbiology; Periodicals; 616
• DOI: 10.1097/IM9.0000000000000101
• Languages: English
• ISSNs: 2096-7241

Abstract

Abstract: The primary defect in cystic fibrosis (CF) is abnormal chloride and bicarbonate transport in the CF transmembrane conductance regulator epithelial ion channel. The apical surface of the respiratory tract is lined by an airway surface liquid (ASL) layer composed of mucin comprising mainly MUC5A and MUC5B glycoproteins. ASL homeostasis depends on sodium bicarbonate secretion into the airways and secretion deficits alter mucus properties leading to airway obstruction, inflammation and infections. Downstream effects of abnormal ion transport in the lungs include altered intrinsic immune defenses. We observed that neutrophils killed Pseudomonas aeruginosa more efficiently when it had been exposed to sodium bicarbonate, and formation of neutrophil extracellular traps by neutrophils was augmented in the presence of increasing bicarbonate concentrations. Physiological levels of bicarbonate sensitized P. aeruginosa to the antimicrobial peptide cathelicidin LL-37, which is present in both lung ASL and neutrophil extracellular traps. Sodium bicarbonate has various uses in clinical medicine and in the care of CF patients and could be further explored as a therapeutic adjunct against Pseudomonas infections.